Precision Medicine: Hype or Hope?

Cardiovascular precision medicine: hope or hype?

An ever-growing number of studies and editorials herald the promise of ‘precision medicine’. On the diagnostic side, new technologies and analytical tools will allow us to pinpoint patient-specific differences and on the treatment side novel therapies will permit us to exploit those differences for better outcomes. A combination of genomic, epigenomic, transcriptomic, and metabolomics informati...

Personalized medicine: hope or hype?

Medicine has always been personalized. For years, physicians have incorporated environmental, behavioural, and genetic factors that affect disease and drug response into patient management decisions. However, until recently, the 'genetic' data took the form of family history and self-reported race/ethnicity. As genome sequencing declines in cost, the availability of specific genomic information...

Personalized medicine: hope or hype.

As Salari et al. state in their recent study, medicine has always been personalized. As more is learnt about diseases, their causes, and how they can be treated, diseases become better characterized. The definitions of diseases become more specific and treatments more tailored to achieve improved outcomes in those who stand to benefit. At the same time, potentially toxic or expensive treatments...

Pharmacogenomics: Hope or Hype?

Much has been made of the potential for personalnot altruistic companies. Incyte Inc. alone holds US ised medicine, where a genomic screen of a patient patents on more than 350 genes and has an estimated could determine which drugs will work and be free of 6,500 applications pending with 10 more applied for side effects in an individual. Much of the hope based each week [3]. They hope to make p...

Genital herpes: hype or hope?